Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that it will present results of 6 studies as poster presentation at the AACR Annual Meeting to be held in Chicago, USA, from April 25-30, 2025.

The AACR Annual Meeting is one of the largest cancer research conferences in the world. The abstracts have been published on the AACR official website.

#01

Title: A B7-H3-targeting antibody-drug conjugate, 7MW3711, and PARP inhibitors synergistically potentiate the antitumor activity in B7-H3-positive cancers

Published Abstract Number: 830

Location: Poster Section 34

Poster Board Number: 18

Session Date and Time: Apr. 27, 2025  2:00 PM-5:00 PM (local time)

#02

Title: Design and synthesis of the novel camptothecin analog MF6 for application into site-specific antibody-drug conjugate

Published Abstract Number: 5733

Location: Poster Section 25

Poster Board Number: 4

Session Date and Time: Apr. 29, 2025  2:00 PM-5:00 PM (local time)

#03

Title: MW-C01/C02, novel CLDN1-targeting antibody-drug conjugates, demonstrate compelling anti-tumor efficacy and favorable safety profiles in preclinical studies

Published Abstract Number: 1573

Location: Poster Section 15

Poster Board Number: 22

Session Date and Time: Apr. 28, 2025  9:00 AM-12:00 PM (local time)

#04

Title: 2MW7061, a novel LILRB4xCD3 bispecific T-cell engager targeting monocytic acute myeloid leukemia

Published Abstract Number: 2116

Location: Poster Section 34

Poster Board Number: 2

Session Date and Time: Apr. 28, 2025  9:00 AM-12:00 PM (local time)

#05

Title: An innovative T cell engager platform with optimized CD3 affinity and formats for targeting hematologic and solid tumors

Published Abstract Number: 2866

Location: Poster Section 15

Poster Board Number: 5

Session Date and Time: Apr. 28, 2025  2:00 PM-5:00 PM (local time)

#06

Title: 7MW4911, a novel cadherin 17-targeting ADC, demonstrates potent efficacy in preclinical models of gastrointestinal cancers

Published Abstract Number: 5466

Location: Poster Section 15

Poster Board Number: 24

Session Date and Time: Apr. 29, 2025  2:00 PM-5:00 PM (local time)